NexPlasmaGen inc.

A cold plasma device killing cancer cells in the surgical cavity after solid tumor removal to reduce cancer recurrence.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Montreal, QC, Canada
  • Currency CAD
  • Founded February 2008
  • Employees 4
  • Incorporation Type C-corp
  • Website nexplasmagen.com

Company Summary

NexPlasmaGen is located in Montreal and was founded by Dr V. Léveillé. It has 15 shareholders. The CHUM is the main clinical partner. Our cold plasma technology kills cancer cells remaining at the tissue margin after solid tumor is removed. Our business model is to sales directly our device to hospitals including disposable recurring items and services revenues based on our device utilization.

Team

  • Valerie Leveille
    CEO

    Chemical Engineer with a PhD and 15-year experience taking innovation from the lab to the market. Have led product development, IP protection, business development, quality management system and SSE processes in a small entreprise. Funded NexPlasmaGen and is leading it since 2008.

Advisors

Previous Investors

  • Axelys
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free